KELLY BENNETT: Open Payments
NPI 1891184875 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 21 payments from 10 companies in 2025. Trend: 2023 $1,520 · 2024 $831 · 2025 $541
Food & beverage: $464Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $304 |
| Janssen Biotech, Inc. | 1 | $77 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| PFIZER INC. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Corium, LLC | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: VRAYLAR, TREMFYA, QULIPTA, ZERBAXA, NURTEC ODT, Azstarys, FANAPT, DYSPORT.
Industry payments across CO — which companies pay providers there.
